Future of convection-enhanced delivery in the treatment of brain tumors
- PMID: 20021213
- DOI: 10.2217/fon.09.135
Future of convection-enhanced delivery in the treatment of brain tumors
Abstract
Gliomas are one of the most lethal forms of cancer. The poor prognosis associated with these malignant primary brain tumors treated with surgery, radiotherapy and chemotherapy has led researchers to develop new strategies for cure. Interstitial drug delivery has been the most appealing method for the treatment of primary brain tumors because it provides the most direct method of overcoming the barriers to tumor drug delivery. By administering therapeutic agents directly to the brain interstitium and, more specifically, to tumor-infiltrated parenchyma, one can overcome the elevated interstitial pressure produced by brain tumors. Convection-enhanced delivery (CED) has emerged as a leading investigational delivery technique for the treatment of brain tumors. Clinical trials utilizing these methods have been completed, with mixed results, and several more are being initiated. However, the potential efficacy of these drugs may be limited by ineffective tissue distribution. The development of computer models/algorithms to predict drug distribution, new catheter designs, and utilization of tracer models and nanocarriers have all laid the groundwork for the advancement of CED. In this review, we summarize the recent past of the clinical trials utilizing CED and discuss emerging technologies that will shape future CED trials.
Similar articles
-
Convection-enhanced delivery in the treatment of malignant glioma.Neurol Res. 2006 Jul;28(5):542-8. doi: 10.1179/016164106X116836. Neurol Res. 2006. PMID: 16808887 Review.
-
Drug delivery strategies for the treatment of malignant gliomas.Int J Pharm. 2012 Oct 15;436(1-2):299-310. doi: 10.1016/j.ijpharm.2012.06.025. Epub 2012 Jun 19. Int J Pharm. 2012. PMID: 22721856 Review.
-
Convection-enhanced delivery: targeted toxin treatment of malignant glioma.Neurosurg Focus. 2006 Apr 15;20(4):E10. Neurosurg Focus. 2006. PMID: 16709015 Review.
-
Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Pharmacol Ther. 2013. PMID: 23694764 Review.
-
Convection-Enhanced Delivery for Management of Malignant Gliomas.Prog Neurol Surg. 2018;32:152-158. doi: 10.1159/000469687. Epub 2018 Jul 10. Prog Neurol Surg. 2018. PMID: 29990981 Review.
Cited by
-
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.Neurosurgery. 2011 Dec;69(6):1272-9; discussion 1279-80. doi: 10.1227/NEU.0b013e3182233e24. Neurosurgery. 2011. PMID: 21562434 Free PMC article.
-
The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.Nat Rev Neurosci. 2011 Aug 3;12(9):495-508. doi: 10.1038/nrn3060. Nat Rev Neurosci. 2011. PMID: 21811295 Review.
-
Convection-enhanced Diffusion: A Novel Tactics to Crack the BBB.Curr Drug Deliv. 2024;21(11):1515-1528. doi: 10.2174/0115672018266501231207095127. Curr Drug Deliv. 2024. PMID: 38275045 Review.
-
Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.Adv Drug Deliv Rev. 2012 May 15;64(7):605-13. doi: 10.1016/j.addr.2011.11.014. Epub 2011 Dec 8. Adv Drug Deliv Rev. 2012. PMID: 22178615 Free PMC article. Review.
-
Pharmacokinetic Principles and Their Application to Central Nervous System Tumors.Pharmaceutics. 2020 Oct 6;12(10):948. doi: 10.3390/pharmaceutics12100948. Pharmaceutics. 2020. PMID: 33036139 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
